Allos Therapeutics is MicroStockProfit.com's Biopharm Feature Stock
June 17 2011 - 5:50AM
MicroStockProfit.com announces an investment report featuring
biopharmaceutical stock Allos Therapeutics Inc. (Nasdaq:ALTH). The
report includes the most recent data from the company's peripheral
T-cell lymphoma treatment study, as well as the Company's financial
position, investment analyses, and industry information you need to
know to make an educated investment decision.
The full report is available at:
www.microstockprofit.com/lp/ALTH
Allos Therapeutics Inc. (ALTH) is a biopharmaceutical company
engaged in the development and commercialization of anti-cancer
therapeutics. The Company is focused on the development and
commercialization of FOLOTYN (pralatrexate injection), a targeted
antifolate inhibitor designed to accumulate preferentially in
cancer cells.
This newsletter has been helping traders make great investment
decisions on ALTH; click here for a 25% discount offer.
In the report, the analyst notes:
"Shares of ALTH spiked more than 8% Thursday after the cancer
drug maker presented data from COMPLETE, an international registry
designed to address the urgent need for an increased understanding
of the treatment patterns and outcomes for patients with peripheral
T-cell lymphoma (PTCL)."
"It is unique in that it is the first registry designed to
characterize treatment patterns across practice settings in the
United States and Europe for patients with PTCL, said Charles
Morris MB ChB, MRCP, chief medical officer at ALTH."
To read the entire report visit:
www.microstockprofit.com/lp/ALTH
See what investors are saying about ALTH at
http://www.stockhideout.com
Get breaking news on ALTH at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment
commentary provider. MicroStockProfit.com strives to provide a
balanced view of many promising small-cap companies that would
otherwise fall under the radar of the typical Wall Street investor.
We provide investors with an excellent first step in their research
and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more
information on MicroStockProfit please visit:
http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: Jay Geller
info@microstockprofit.com
1-888-307-2850
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart
From Jul 2023 to Jul 2024